Indications
- Analgesic/Anti-Pyretic: widely used after its introduction in 1887 until it was banned by the FDA in 1983
Pharmacology
- Metabolized to Paracetamol
Administration
- PO
Adverse Effects
Oncologic Adverse Effects
- Increased Risk of Specific Malignancies
Renal Adverse Effects
- Acute Kidney Injury (AKI) (see Acute Kidney Injury, [[Acute Kidney Injury]])
Toxicologic Adverse Effects
- Methemoglobinemia (see Methemoglobinemia, [[Methemoglobinemia]])
References
- xxxx